Career Enhancement Program

职业提升计划-项目摘要 职业提升计划(CEP)的目标是吸引、发展和监督最有前途的 肝胆癌转译研究的研究人员。为了达到这些目标， 孢子CEP旨在： 确定最有希望的候选人 强调招聘合格的妇女、少数群体和残疾人 对所有申请者进行彻底评估 评估和监督CEP奖获得者的职业发展和指导 促进外部资金和获奖者融入未来的孢子项目 CEP面向梅奥诊所校区的初级教职员工和职业生涯中期早期教职员工，他们将 致力于在翻译、多学科基础、临床或以人群为基础的指导下进行职业发展 肝胆管癌的研究。指导团队由两位资深肝胆癌研究人员组成， 梅奥诊所与其他癌症研究领域的高效率研究人员一起工作。辅导是 伴随着孢子领导层的严密监督。CEP主任将向孢子报告 总干事和孢子内部咨询委员会。梅奥诊所通过其无缝融合的患者护理和 基础和应用研究设施，有利于这种类型的指导性翻译研究的环境。 由于梅奥在招聘教员方面竞争激烈，因此不断涌现出一批早期但杰出的教师， 科学家和临床医生(包括才华横溢的女性和少数族裔研究人员)将从我们的 孢子的建议CEP从事翻译研究，重点是肝胆癌。我们有 制定了招募、挑选和评估获奖者的正式机制，并将确保 获奖者融入孢子研究环境。明确的预期是获奖者 将利用向他们提供的资源来开发独立的研究计划，并 在肝胆癌研究中获得独立资金。一项最高可达10万美元的年度奖励将 (从孢子赠款中获得5万美元，梅奥诊所癌症中心的支持与之匹配)。

CAREER ENHANCEMENT PROGRAM – PROJECT SUMMARY The goal of the Career Enhancement Program (CEP) is to attract, develop, and monitor the most promising investigators for translational research in hepatobiliary cancer. To meet these objectives, the aims of the SPORE CEP are designed to:  identify the most promising candidates  emphasize the recruitment of qualified women, minorities, and persons with disabilities  conduct a thorough evaluation of all applicants  evaluate and monitor career development and mentoring of CEP awardees  facilitate extramural funding and integration of awardees into future SPORE projects The CEP is targeted to both junior faculty and early mid-career faculty at any Mayo Clinic campus who will commit to mentored career development in translational, multidisciplinary basic, clinical or population-based hepatobiliary cancer research. Mentoring teams consist of both senior hepatobiliary cancer researchers at Mayo Clinic together with highly productive investigators in other areas of cancer research. Mentoring is accompanied by close oversight by the SPORE leadership. The Director of the CEP will report to the SPORE Director and the SPORE Internal Advisory Board. Mayo Clinic has, by its seamless blend of patient care and basic and applied research facilities, an environment conducive to this type of mentored translational research. In that Mayo is highly competitive in recruiting faculty, there is a continuous pool of early, but outstanding, scientists and clinicians (including talented female and minority investigators) who would benefit by our SPORE’s proposed CEP to engage in translational research with a focus on hepatobiliary cancer. We have developed a formal mechanism for recruiting, selecting, and evaluating awardees, and will ensure that awardees are integrated into the SPORE research environment. The explicit expectation is that the awardees will utilize the resources made available to them for the development of independent research programs and acquisition of independent funding in hepatobiliary cancer research. One annual award for up to $100,000 will be made ($50K from the SPORE grant, matched by Mayo Clinic Cancer Center support).